Characterization of the rapamycin-inducible EBV LMP1 activation system
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sang Yong | - |
dc.contributor.author | Kim, Jung-Eun | - |
dc.contributor.author | Won, Jiyeon | - |
dc.contributor.author | Song, Yoon-Jae | - |
dc.date.available | 2020-02-28T07:45:50Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-10 | - |
dc.identifier.issn | 1225-8873 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10097 | - |
dc.description.abstract | Epstein-Barr virus (EBV) latent infection membrane protein 1 (LMP1) is required for EBV-mediated B lymphocyte transformation into proliferating lymphoblastoid cell lines (LCL). LMP1 oligomerizes spontaneously in membrane lipid rafts via its transmembrane domain and constitutively activates signal transduction pathways, including NF-kappa B, p38 Mitogen-Activated Protein Kinase (MAPK), and c-Jun N-terminal ICinase (INK). Since LMP1 mimics the tumor necrosis factor receptor (TNFR), CD40, it may be effectively utilized to study the effects of constitutive activation of signal transduction pathways on cellular physiology. On the other hand, LMP1 presents a disadvantage in terms of determining the sequential events and factors involved in signaling pathways. A CD40-LMP1 chimeric molecule has been generated to overcome this limitation but does not represent the authentic and physiological nature of LMP1. In the current study, a ligand-dependent activation system for LMP1 using rapamycin-inducible dimerization was generated to delineate the LMP1 signaling pathway. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MICROBIOLOGICAL SOCIETY KOREA | - |
dc.relation.isPartOf | JOURNAL OF MICROBIOLOGY | - |
dc.title | Characterization of the rapamycin-inducible EBV LMP1 activation system | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000362156300010 | - |
dc.identifier.doi | 10.1007/s12275-015-5455-z | - |
dc.identifier.bibliographicCitation | JOURNAL OF MICROBIOLOGY, v.53, no.10, pp.732 - 738 | - |
dc.identifier.kciid | ART002032488 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84942892119 | - |
dc.citation.endPage | 738 | - |
dc.citation.startPage | 732 | - |
dc.citation.title | JOURNAL OF MICROBIOLOGY | - |
dc.citation.volume | 53 | - |
dc.citation.number | 10 | - |
dc.contributor.affiliatedAuthor | Kim, Sang Yong | - |
dc.contributor.affiliatedAuthor | Kim, Jung-Eun | - |
dc.contributor.affiliatedAuthor | Won, Jiyeon | - |
dc.contributor.affiliatedAuthor | Song, Yoon-Jae | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Epstein-Barr virus | - |
dc.subject.keywordAuthor | latent membrane protein 1 | - |
dc.subject.keywordAuthor | NF-kappa B | - |
dc.subject.keywordPlus | EPSTEIN-BARR-VIRUS | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | MEMBRANE-PROTEIN 1 | - |
dc.subject.keywordPlus | LYMPHOCYTE GROWTH TRANSFORMATION | - |
dc.subject.keywordPlus | LATENT MEMBRANE-PROTEIN-1 | - |
dc.subject.keywordPlus | MAMMALIAN PROTEIN | - |
dc.subject.keywordPlus | RECEPTOR FAMILY | - |
dc.subject.keywordPlus | ENGAGES | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | DOMAIN | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.